Showing results (971-980 of 1,883) with videos related to

Sort By:
Pageof 189
Organic Letters|August 25, 2017
Construction of the [6,5,7,5] Tetracyclic Core of Calyciphylline A Type Alkaloids via a Tandem Semipinacol Rearrangement/Nicholas ReactionHui Shao, Wen Bao, Ze-Ran Jing, et al.
Frontiers in Cardiovascular Medicine|December 8, 2025
Acute aortic dissection-induced acute respiratory distress syndrome: pathogenesis and clinical implicationsWen-Jun Zhou, Hong-Ye Wu, Jia-Xuan Wang, et al.
Journal of Asian Natural Products Research|June 21, 2025
A novel pyrrolidine alkaloid and a novel isoflavone with anti-inflammatory activity from the tubers of <i>Arisaema franchetianum</i>Wan-Qi Yang, Meng-Yuan Cui, Yun-Peng Qin, et al.
Journal of Multidisciplinary Healthcare|February 12, 2024
Factors Associated with Acute Pulmonary Embolism in Patients with Hypoxia After off-Pump Coronary Artery Bypass Grafting: A Case-Control StudyHai-Yan Yu, Yun-Peng Bai, Xu-Chen Song, et al.
Natural Product Research|February 1, 2024
Two new acorane-type sesquiterpenoids from an endophytic <i>Trichoderma harzianum</i> associated with <i>Paeonia lactiflora</i> PallYun-Peng Sun, Man-Li Zhang, Yang Yu, et al.
Animals : an Open Access Journal From MDPI|March 28, 2026
Prevalence and Multi-Locus Genotyping of <i>Enterocytozoon bieneusi</i> in Dogs from Fujian Province, Southeast ChinaKai Hu, Yanlong Gu, Sheng-Jie Tang, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|October 29, 2023
Geographical provenance variation of growth and wood properties of 18-year-old <i>Schima superba</i>Miao Wang, Guo-Liang Wu, Rui Zhang, et al.
Scientific Reports|June 24, 2016
Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and ErkMei Peng, Yanjun Huang, Ting Tao, et al.
Oncotarget|April 14, 2016
Yin Yang-1 increases apoptosis through Bax activation in pancreatic cancer cellsJing-Jing Zhang, Yi Zhu, Chuang Yang, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2025
Single- and multiple-dose pharmacokinetics and safety of the SARS-CoV-2 3CL protease inhibitor RAY1216: a phase 1 study in healthy participantsYue Hu, Haijun Li, Kun Wang, et al.
Pageof 189